Patents
Patents for C07C 259 - Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups (4,411)
05/1993
05/13/1993WO1993009088A1 Improved method for synthesis of desferrioxamine b, analogs and homologs thereof
05/13/1993CA2122046A1 Hydroxamic acid derivative
05/12/1993CA2082566A1 Fused benzeneoxyacetic acid derivatives
05/05/1993EP0231388B1 Surface machining method
05/04/1993US5208355 Cosmetic composition
04/1993
04/29/1993WO1993007867A1 SUBSTITUTED β-AMINO ACID DERIVATIVES USEFUL AS PLATELET AGGREGATION INHIBITORS
04/28/1993EP0538384A1 Oxamides
04/28/1993EP0538291A1 Intermediate used for the preparation of deferoxamine.
04/27/1993CA1316935C Hydroxamic acid derivatives
04/15/1993WO1993007148A1 Novel potent inducers of terminal differentiation and methods of use thereof
04/13/1993US5202349 Substituted phenylacetylenes, pharmaceutical compositions containing these compounds and processes for the preparation of these compounds and compositions
04/06/1993US5200426 Preventing the growth or differentiation of common acute lymphoblastic leukemia antigen and human leukemia cells
03/1993
03/30/1993CA1315279C Anti-inflammatory agents
03/23/1993US5196412 Treatment of excess calcium
03/23/1993CA1314903C Amides of cyclomethylen-1,2-bicarboxylic acids having therapeutical activity, processes for their preparation and pharmaceutical compositions containing them
03/16/1993CA1314655C Hydroxylamine derivatives
03/09/1993US5192358 Oxalic acid derivatives, their preparation and plant growth regulators containing them
03/04/1993WO1992015555A3 Fluoroalkenyl compounds and their use as pest repellents
02/1993
02/23/1993US5189178 Preventing protein destruction
02/18/1993WO1993003045A1 Process for purer organic metal ion chelate complexes
02/17/1993EP0527131A1 Chelants
02/16/1993US5187192 Amide derivatives as antiinflammatory or antiallergy agents
02/09/1993US5185368 Complex with trivalent metal ions; medical diagnosis and therapy
02/04/1993WO1993002047A1 N-ethyl hydroxamic acid chelants
02/04/1993WO1993002045A1 Hydroxamate and hydrazide derivatives of polyamines and their medical use as chelating agents
02/02/1993US5183900 Matrix metalloprotease inhibitors
02/02/1993US5183828 Ribonucleotide reductase inhibitor and free radical scavenger
02/02/1993US5183584 Detergent containing an inorganic persalt and an oxygen-releasing compound; excellent antisoilant at low temperature washing
01/1993
01/27/1993EP0524517A1 Substituted 3,4-dihydronaphthalenes, medicament containing them and process for their preparation
01/24/1993CA2070495A1 Substituted 3,4-dihydronaphthalenes, pharmaceutical compositions containing these compounds and processes for the preparation of these compounds and compositions
01/21/1993WO1992022523A3 Peptide derivatives of collagenase inhibitor
01/19/1993US5180742 Lipoxygenase Inhibitors
01/19/1993CA1312871C Indene and naphthalene derivatives
01/13/1993EP0522000A1 5-lipoxygenase inhibitors
01/07/1993WO1993000327A1 Linear hydroxamates, their preparation and pharmaceutical compositions comprising them for treatment of iron and aluminium overload
12/1992
12/31/1992WO1993000082A1 Pharmaceutical compositions comprising hydroxamate derivatives for iron removal
12/31/1992CA2090426A1 Pharmaceutical compositions comprising hydroxamate derivatives for iron removal
12/29/1992US5175191 Potent inducers of terminal differentiation and methods of use thereof
12/29/1992US5174917 Compositions containing n-ethyl hydroxamic acid chelants
12/23/1992WO1992022523A2 Peptide derivatives of collagenase inhibitor
12/10/1992WO1992021648A1 Amino acid derivative anticonvulsant
12/02/1992EP0515420A1 Nitric acid esters of cyclohexanol derivatives.
11/1992
11/26/1992WO1992020227A1 Substituted orally effective ion chelators related to deferoxamine
11/24/1992US5166402 Herbicidal α-(5-aryloxy-naphthalen-1-yl-oxy)-propionic acid derivatives
10/1992
10/16/1992WO1992018487A1 Substituted-2-phenyl-3-methoxypropenoates as fungicides
10/16/1992CA2107084A1 Fungicides
10/13/1992US5155228 FK-506 C10-C18 process intermediates
09/1992
09/30/1992EP0505467A1 Pharmacologically active amide carboxylate derivatives
09/22/1992US5149859 Cardiovascular disorders
09/22/1992US5149845 Hydoxamate
09/17/1992WO1992015555A2 Fluoroalkenyl compounds and their use as pest repellents
09/17/1992CA2104005A1 Fluoroalkenyl compounds and their use as pest repellents
09/16/1992CN1064479A Fluoroalkenyl compounds and their use as pest repellents
09/15/1992US5147879 O-(3-amino-2-hydroxypropyl)-hydroximic acid halides and process for preparing the same
09/09/1992EP0502709A1 Gallium compounds
09/07/1992CA2061653A1 Oral gallium complexes
08/1992
08/18/1992US5140040 Alpha-2-adrenergic receptor antagonist; glaucoma; congestive heart failure; hypotensive agents; headaches; metabolic disorders (diabetes, obesity)
08/18/1992US5140035 Fungicidal triazolymethyl-cyclopropyl derivatives
08/12/1992EP0498665A1 Hydroxamic acids derivatives, process for their preparation and use thereof
08/08/1992WO1992013831A1 Hydroxamic acid derivatives, process for their preparation and use thereof
08/08/1992CA2100661A1 Hydroxamic acid derivatives, process for their preparation and use thereof
08/05/1992EP0497192A2 Amino acid derivatives
08/02/1992CA2058797A1 Amino acid derivatives
07/1992
07/29/1992EP0495917A1 Lipoxygenase inhibitors
07/14/1992US5130479 Hydrolytically degradable hydrophilic gels and the method for preparation thereof using n,o-dimethacryloylhydroxylamine as a cross-linking agent
07/08/1992CN1062536A Retroviral protease inhibitors derived from 3-chloro-2-chloromethyl-1-propene
07/07/1992US5128362 Antidepressant, antiglaucoma
07/01/1992EP0492136A2 Retroviral protease inhibitors derived from 3-chloro-2-chloromethyl-1-propene
06/1992
06/30/1992CA1304391C Lipoxygenase inhibiting compounds
06/23/1992US5124480 Peroxygen bleach activators and bleaching compositions
06/23/1992US5124421 Addition polymers crosslinked with N,O-dimethacryloylhydroxylamine; oral drug delivery; sustained release in the duodenum
06/21/1992CA2057972A1 Retroviral protease inhibitors derived from 3-chloro-2-chloromethyl-1-propene
06/13/1992WO1992010469A1 Hydroxamic acid derivatives which inhibit lipoxygenase
06/13/1992CA2094247A1 Hydroxamic acid derivatives which inhibit lipoxygenase
06/11/1992WO1992009567A1 Anti-inflammatory compounds
06/11/1992WO1992009566A1 Novel hydroxamic acid and n-hydroxyurea derivatives and their use
06/11/1992WO1992009563A1 Improved matrix metalloprotease inhibitors
06/11/1992WO1992009282A1 Treatment for tissue ulceration
06/11/1992CA2096225A1 Matrix metalloprotease inhibitors
06/10/1992EP0489579A1 Peptidyl derivatives
06/10/1992EP0489577A1 Peptidyl derivatives
06/10/1992CN1061775A Hydroxamic acid and n-hydroxyurea derivatives and their use
06/09/1992US5120869 Herbicidal compounds
06/09/1992US5120752 Cyclopropyl derivative lipoxygenase inhibitors
06/04/1992WO1992009565A1 Peptidyl derivatives
06/04/1992WO1992009564A1 Peptidyl derivatives
06/04/1992CA2073513A1 Peptidyl derivatives
06/04/1992CA2073510A1 Peptidyl derivatives
06/02/1992US5118844 New fluorinated alkoxy imines and their n-chloro- and n-bromo-derivatives, and process for their preparation
05/1992
05/22/1992WO1992009556A1 Improved matrix metalloprotease inhibitors
05/22/1992CA2096221A1 Matrix metalloprotease inhibitors
05/19/1992US5114953 Peptides
05/19/1992CA1301188C N-phenylalkylbenzamide fungicides
05/16/1992WO1992008453A1 Hydroxamic acids for preventing reperfusion injury
05/16/1992CA2095606A1 Hydroxamic acids for preventing reperfusion injury
05/12/1992US5112846 Nonsteroidal antiinflammatory agents
05/01/1992WO1992007822A1 Intermediates in the preparation of 4,5-difluoroanthranilic acid
04/1992
04/16/1992WO1991008737A3 Pharmacologically active amide carboxylate derivatives
04/15/1992EP0334863B1 Process for the preparation of organo n-hydroxyimidates
04/15/1992CN1060286A Antiinflammatory hydroxamic acids and n-hydroxyureas
1 ... 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45